Generic placeholder image

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)


ISSN (Print): 1871-5222
ISSN (Online): 1875-6115

Tetrac-Conjugated Quantum Dots for Diagnosis and Treatment of Pancreatic Cancer: An In Vitro Evaluation

Author(s): Dhruba J. Bharali, Usawadee Dier, Paul J. Davis and Shaker A. Mousa

Volume 9, Issue 4, 2009

Page: [219 - 223] Pages: 5

DOI: 10.2174/187152209790773048

Price: $65


We report a preliminary investigation of the use of pegylated quantum dots (PEG-QDs) conjugated to tetraiodothyroacetic acid (tetrac), a thyroid hormone antagonist and anti-proliferative agent, as a luminescent probe for live cell imaging and treatment of human pancreatic cancer. PEG-QDs were conjugated to epoxyactivated tetrac through primary amino groups present on the PEG-QDs. Cellular entry of tetrac-conjugated PEG-QDs (tetrac-PEG-QDs) in vitro was examined by confocal microscopy and effects of PEG-QDs on cell proliferation were examined by CyQUANT® Cell Proliferation Assay. Tetrac-PEG-QDs exhibited a higher level of entry into pancreatic cancer (PANC-1) cells than unconjugated PEG-QDs. In addition, pre-incubation of cells with the thyroid hormone analogue L-thyroxine (T4) increased fluorescent intensity, indicating enhanced uptake of tetrac-PEG-QDs. Proliferation of PANC-1 cells was significantly inhibited by treatment with tetrac-PEG-QDs.

Keywords: Quantum dots, tetrac, pancreatic cancer, confocal microscopy, cell proliferation, PANC-1 cells

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy